An inhibitor of Bcl-2 family proteins induces regression of solid tumours-Reference-Cited by-同舟云学术

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Published:2005-05-15 Issue:7042 Volume:435 Page:677-681
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Oltersdorf Tilman,Elmore Steven W.,Shoemaker Alexander R.,Armstrong Robert C.,Augeri David J.,Belli Barbara A.,Bruncko Milan,Deckwerth Thomas L.,Dinges Jurgen,Hajduk Philip J.,Joseph Mary K.,Kitada Shinichi,Korsmeyer Stanley J.,Kunzer Aaron R.,Letai Anthony,Li Chi,Mitten Michael J.,Nettesheim David G.,Ng ShiChung,Nimmer Paul M.,O'Connor Jacqueline M.,Oleksijew Anatol,Petros Andrew M.,Reed John C.,Shen Wang,Tahir Stephen K.,Thompson Craig B.,Tomaselli Kevin J.,Wang Baole,Wendt Michael D.,Zhang Haichao,Fesik Stephen W.,Rosenberg Saul H.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature03579.pdf

Reference30 articles.

1. Daniel, N. N. & Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205–219 (2004)

2. Kirkin, V., Joos, S. & Zörnis, M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta 1644, 229–249 (2004)

3. Amundson, S. A. et al. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60, 6101–6110 (2000)

4. Reed, J. C. Promise and problems of Bcl-2 antisense therapy. J. Natl Cancer Inst. 89, 988–990 (1997)

5. Letai, A., Sorcinelli, M. D., Beard, C. & Korsmeyer, S. J. Antiapoptotic Bcl-2 is required for maintenance of a model leukemia. Cancer Cell 6, 241–249 (2004)

Cited by 3038 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rescaling NMR for a Larger Deployment in Drug Discovery: Hyperpolarization and Benchtop NMR as Potential Game‐Changers;Chemistry–Methods;2024-09-05

2. APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways;International Immunopharmacology;2024-09

3. Overview of BH3 mimetics in ovarian cancer;Cancer Treatment Reviews;2024-09

4. Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking;Science Advances;2024-08-30

5. Biomarker-directed therapy in multiple myeloma;Current Opinion in Oncology;2024-08-23